Bradmer Pharmaceuticals Inc. (TSE:GLX) Receives Average Recommendation of “Buy” from Analysts

Shares of Bradmer Pharmaceuticals Inc. (TSE:GLX) have earned an average recommendation of “Buy” from the seven brokerages that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, one has issued a buy recommendation and four have given a strong buy recommendation to the company.

GLX has been the subject of a number of research analyst reports. Citigroup raised shares of Bradmer Pharmaceuticals to a “hold” rating in a research note on Tuesday, February 24th. ATB Cormark Capital Markets downgraded shares of Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a report on Thursday, February 5th. Finally, Chardan Capital upgraded shares of Bradmer Pharmaceuticals to a “strong-buy” rating in a report on Monday, May 4th.

Bradmer Pharmaceuticals Price Performance